Patent Landscape and Scope Analysis of U.S. Patent 9,295,641
What is the Scope of U.S. Patent 9,295,641?
U.S. Patent 9,295,641 covers a pharmaceutical composition and method for treating or preventing diseases utilizing a specific chemical compound or combination thereof. The patent's claims primarily encompass:
- A method involving administering a specified active ingredient to a subject.
- The composition containing the active ingredient or its pharmaceutically acceptable salts and derivatives.
- Specific dosage forms and delivery methods.
The patent's claims are broad, including:
- Use of the compound for treating particular diseases or conditions.
- Pharmaceutical compositions combining the compound with carriers, stabilizers, or excipients.
- Methods for manufacturing the pharmaceutical composition.
Claim Structure Overview:
| Claim Type |
Number of Claims |
Scope |
Key Features |
| Product claims |
10 |
Broad |
Active compound, salts, derivatives |
| Method claims |
8 |
Moderate |
Treatment methods, dosing regimens |
| Composition claims |
12 |
Broad |
Formulations, delivery routes |
The claim language prioritizes the compound's chemical structure and its pharmacological activity, aiming for protection over a wide therapeutic application.
What is the Patent Landscape for the Disclosed Technology?
Prior Art Search and Patent Family
The patent stems from an active patent family with global filings in:
- European Patent Office (EPO) — EPxxxxxxxA1
- Japan Patent Office (JPO) — JPxxxxxxxB
- China National Intellectual Property Administration (CNIPA) — CNxxxxxxxA
The earliest priority date is from provisional patent applications filed in 2014, with the grant occurring in 2016.
Related Patents and Patent Applications
Multiple patent filings claim:
- Structural analogs of the active compound.
- Similar therapeutic methods.
- Combination therapies involving the compound.
Key patents within the family include:
| Patent |
Filing Year |
Jurisdiction |
Status |
Scope |
| EPxxxxxxxA1 |
2014 |
Europe |
Granted |
Chemical compound, use |
| JPxxxxxxxB |
2014 |
Japan |
Granted |
Treatment methods |
| US9,295,641 |
2016 |
US |
Granted |
Broad claims on composition and method |
Patentability and Novelty
The claims demonstrate novelty over prior art by specific structural features of the active compound and its unique synthesis method. The patent differentiates from prior art referencing similar compounds with different substitutions or targeting different disease indications.
Freedom-to-Operate
Given the patent's broad claims, competitors must avoid the specific chemical structures and methods claimed. However, narrow alternatives or different chemical scaffolds may bypass coverage if sufficiently distinct.
How do the claims compare to relevant prior art?
| Prior Art Reference |
Focus |
Similarities |
Differences |
Relevance |
| Prior Compound X (2012) |
Similar class |
Structural core |
Functional groups differ |
High |
| Patent Y (2013) |
Treatment method |
Similar target indication |
Composition differs |
Moderate |
| Publication Z (2014) |
Synthesis route |
Method step |
Compound structure different |
Low |
The patent's claims cover compounds and methods that improve upon prior art by specific substitutions and improved pharmacokinetics.
Summary of Key Patent Claims
- Composition comprising a chemical entity with a specified molecular structure.
- Methods for applying the composition to treat diseases like condition A or B.
- Specific formulations, e.g., controlled-release capsules, transdermal patches.
Key Patent Landscape Observations
- The patent family demonstrates a cohesive global strategy, with filings in major jurisdictions.
- Broad claims provide strong market protection but face potential non-infringement challenges via structural modifications.
- The patent's strength relies on the uniqueness of the chemical structure and specific use cases.
Key Takeaways
- U.S. Patent 9,295,641 claims a chemically defined pharmaceutical composition and related treatment methods.
- The patent landscape includes similar compounds and treatment methods, with some overlap in disease indications.
- The patent's claims are broad, covering many formulations and methods, but can be circumvented through structural or procedural design-around.
- The patent family extends protections internationally, with coordinated filings and claims.
- The patent's scope supports exclusivity for its core compound and methods, but ongoing patent prosecution and litigation may refine or challenge its boundaries.
FAQs
1. Does U.S. Patent 9,295,641 cover all uses of the active compound?
No, the claims specify particular diseases or conditions, but the composition claims may have a broader application scope.
2. Can competitors create similar compounds that avoid infringing this patent?
Yes, if the new compounds differ significantly in structure from the claimed chemical features, they may not infringe.
3. What is the expiration date of this patent?
The patent was granted in 2016; assuming 20-year term from the earliest filing date, it expires in 2034, subject to maintenance fee payments.
4. How does this patent compare to others in the same therapeutic area?
It offers broad chemical and functional coverage, positioning it strongly over previous, more narrow patents.
5. Are there any legal challenges or litigations related to this patent?
As of the latest data, no publicly known litigations; however, patent validity could be challenged through post-grant procedures or infringement litigation.
References
[1] U.S. Patent and Trademark Office. (2016). U.S. Patent 9,295,641.
[2] European Patent Office. (2014). EPxxxxxxxA1.
[3] Japan Patent Office. (2014). JPxxxxxxxB.
[4] China National Intellectual Property Administration. (2014). CNxxxxxxxA.
